Sommerer, C., Suwelack, B., Dragun, D., & Schenker, P. (2019). An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients. Kidney international, 96(1), . https://doi.org/10.1016/j.kint.2019.01.041
Chicago-Zitierstil (17. Ausg.)Sommerer, Claudia, Barbara Suwelack, Duska Dragun, und Peter Schenker. "An Open-label, Randomized Trial Indicates That Everolimus with Tacrolimus or Cyclosporine Is Comparable to Standard Immunosuppression in De Novo Kidney Transplant Patients." Kidney International 96, no. 1 (2019). https://doi.org/10.1016/j.kint.2019.01.041.
MLA-Zitierstil (9. Ausg.)Sommerer, Claudia, et al. "An Open-label, Randomized Trial Indicates That Everolimus with Tacrolimus or Cyclosporine Is Comparable to Standard Immunosuppression in De Novo Kidney Transplant Patients." Kidney International, vol. 96, no. 1, 2019, https://doi.org/10.1016/j.kint.2019.01.041.